Skip to main content
. 2024 Dec 11;11:1509168. doi: 10.3389/fmed.2024.1509168

FIGURE 1.

FIGURE 1

PCSK9 inhibitor ameliorates bleomycin (BLM)-induced cardiopulmonary remodeling and function (A) Representative images of mice lung sections stained by hematoxylin and eosin (H&E), the frame points to pulmonary arteries. (B) Quantitative assessment of the pulmonary artery lumen to total area ratio. (C) Statistical analysis of the pulmonary arterial wall thickness percentage (WT%). (D) Statistical analysis of the right ventricle hypertrophy index (RVHI). (E) RV hypertrophy shown by H&E staining. (F) Representative right ventricular systolic pressure (RVSP) curve. (G) Statistical analysis of RVSP. *p < 0.05 and ***p < 0.001 versus CON group. ##p < 0.01 and ###p < 0.001 versus BLM group.